Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

IL-15 promotes hair growth and protects hair follicles.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

UV rays can cause a type of hair loss known as telogen alopecia.

Pimecrolimus cream is not effective for treating alopecia areata.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Combining light therapy, acid, and microneedling improves hair regrowth in stubborn hair loss cases.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Dupilumab can improve both atopic dermatitis and alopecia universalis.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

A 6-year-old girl with alopecia universalis regrew most of her hair after treatment with simvastatin/ezetimibe, minoxidil, and prednisolone.

The conclusion is that emotional support and a variety of treatments are important for alopecia areata, but more research is needed.

The study concluded that a 'Swiss cheese' pattern in hair follicles is a useful sign for diagnosing alopecia areata.

Alopecia areata does not affect areas with psoriasis plaques.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Photodynamic therapy with methyl 5-aminolevulinic acid is ineffective for treating alopecia totalis.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.